Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GENPHARMASEC LTD.

NSE : NABSE : 531592ISIN CODE : INE861N01036Industry : Dyes & PigmentsHouse : Private

BSE2.060 (0 %)

PREV CLOSE ( ) 2.06

OPEN PRICE ( ) 2.04

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 295918

TODAY'S LOW / HIGH ( )2.04 2.08

52 WK LOW / HIGH ( ) 1.894.32

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2024

Mar 2023

Operational & Financial Ratios

Earnings Per Share (Rs)

0.00

0.04

CEPS(Rs)

0.00

0.02

DPS(Rs)

0.00

Book NAV/Share(Rs)

1.16

0.55

Tax Rate(%)

167.56

-299.43

Margin Ratios

Core EBITDA Margin(%)

0.15

1.01

EBIT Margin(%)

2.17

1.32

Pre Tax Margin(%)

0.82

1.10

PAT Margin (%)

-0.56

4.41

Cash Profit Margin (%)

-0.42

4.49

Performance Ratios

ROA(%)

-0.38

5.91

ROE(%)

-0.42

7.34

ROCE(%)

1.53

1.83

Asset Turnover(x)

0.68

1.34

Sales/Fixed Asset(x)

55.92

166.66

Working Capital/Sales(x)

0.79

1.51

Efficiency Ratios

Fixed Capital/Sales(x)

0.02

0.01

Receivable days

88.89

81.67

Inventory Days

111.15

138.41

Payable days

28.23

21.37

Valuation Parameters

PER(x)

0.00

46.00

PCE(x)

-970.75

75.24

Price/Book(x)

1.92

5.62

Yield(%)

0.00

EV/Net Sales(x)

3.55

3.42

EV/Core EBITDA(x)

153.67

244.10

EV/EBIT(x)

163.47

258.27

EV/CE(x)

1.60

4.74

M Cap / Sales

4.06

3.37

Growth Ratio

Net Sales Growth(%)

19.16

0.00

Core EBITDA Growth(%)

96.50

0.00

EBIT Growth(%)

95.44

0.00

PAT Growth(%)

-115.05

0.00

EPS Growth(%)

-105.67

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.05

0.20

Current Ratio(x)

15.16

9.17

Quick Ratio(x)

11.89

4.48

Interest Cover(x)

1.61

6.03

Total Debt/Mcap(x)

0.03

0.04